Eisai Co Ltd

4523

Company Profile

  • Business description

    Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

  • Contact

    4-6-10 Koishikawa
    Bunkyo-ku
    Tokyo112-8088
    JPN

    T: +81 338173030

    https://www.eisai.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    10,917

Stocks News & Analysis

stocks

ASX tech share tracking below guidance

Moat Rating downgraded for overvalued shares.
stocks

After plunge ASX blue chip undervalued

This company earns a moat from our analysts.
stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,733.7065.70-0.75%
CAC 407,981.765.73-0.07%
DAX 4024,400.6592.730.38%
Dow JONES (US)49,363.88322.24-0.65%
FTSE 10010,330.556.800.07%
HKSE25,576.43221.42-0.86%
NASDAQ25,870.71220.02-0.84%
Nikkei 22559,764.16786.43-1.30%
NZX 50 Index12,820.21154.11-1.19%
S&P 5007,353.6149.44-0.67%
S&P/ASX 2008,511.3061.80-0.72%
SSE Composite Index4,144.0425.50-0.61%

Market Movers